Research develop a revolutionary toolkit to combat digital exclusion

Researchers create a composite indicator for digital exclusion and a related toolbox.

Antibody-Drug Conjugate Boosts Survival in Recurrent/Metastatic Cervical Cancer

MADRID — Treatment with tisotumab vedotin (Tivdak) significantly extended overall survival (OS) compared with chemotherapy in patients with recurrent or metastatic cervical cancer, the phase

October 24, 2023

States join Oklahoma effort to convince Supreme Court to let them regulate PBMs

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 13, 2024

New study highlights the need for advanced pneumococcal vaccines in the wake of pre-COVID data

The risk factors associated with CAP caused by serotypes in the different pneumococcal vaccines.

December 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.